Circadian biology to advance therapeutics for mood disorders

被引：7
|
作者：
Bhatnagar, Apoorva [1 ,2 ]
Murray, Greg [2 ]
Ray, Sandipan [1 ]
机构：
[1] Indian Inst Technol Hyderabad, Dept Biotechnol, Sangareddy 502284, Telangana, India
[2] Swinburne Univ Technol, Ctr Mental Hlth, Melbourne, Vic, Australia
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2023年 / 44卷 / 10期
基金：
英国惠康基金;
关键词：
GENE-EXPRESSION; CLOCK; RHYTHMS; TIME; DEPRESSION; MELATONIN; METABOLISM; ACTIVATION; REWARD; ATLAS;
D O I：
10.1016/j.tips.2023.07.008
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Mood disorders account for a significant global disease burden, and pharmacological innovation is needed as existing medications are suboptimal. A wide range of evidence implicates circadian and sleep dysfunction in the pathogenesis of mood disorders, and there is growing interest in these chronobiological pathways as a focus for treatment innovation. We review contemporary evidence in three promising areas in circadian-clock-based therapeutics in mood disorders: targeting the circadian system informed by mechanistic molecular advances; time-tailoring of medications; and personalizing treatment using circadian parameters. We also consider the limitations and challenges in accelerating the development of new circadian-informed pharmacotherapies for mood disorders.
引用
收藏
页码：689 / 704
页数：16
相关论文
共 50 条
  • [41] New interventions for disturbances in sleep and circadian rhythms in mood disorders
    Gunnar, M.
    [J]. BIPOLAR DISORDERS, 2015, 17 : 26 - 26
  • [42] Circadian rhythm disturbances in mood disorders: characterisation and clinical impact
    Cappannini, G.
    Bianchi, S.
    Menculini, G.
    Semeraro, B.
    De Giorgi, F.
    Amantini, K.
    Moretti, P.
    Tortorella, A. A. V.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S197 - S197
  • [43] Circadian rhythm disturbances in mood disorders: characterisation and clinical impact
    Cappannini, G.
    Bianchi, S.
    Menculini, G.
    Semeraro, B.
    De Giorgi, F.
    Amantini, K.
    Moretti, P.
    Tortorella, A. A. V.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S197 - S197
  • [44] Circadian rhythmicity in emerging mood disorders: state or trait marker?
    Ashlee B. Grierson
    Ian B. Hickie
    Sharon L. Naismith
    Daniel F. Hermens
    Elizabeth M. Scott
    Jan Scott
    [J]. International Journal of Bipolar Disorders, 4
  • [45] Circadian rhythmicity in emerging mood disorders: state or trait marker?
    Grierson, Ashlee B.
    Hickie, Ian B.
    Naismith, Sharon L.
    Hermens, Daniel F.
    Scott, Elizabeth M.
    Scott, Jan
    [J]. INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2016, 4 : 1 - 7
  • [46] The circadian basis of mood disorders: Recent developments and treatment implications
    Monteleone, Palmiero
    Maj, Mario
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (10) : 701 - 711
  • [47] Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders
    Rafael T de Sousa
    Alexandre A Loch
    André F Carvalho
    André R Brunoni
    Marie Reine Haddad
    Ioline D Henter
    Carlos A Zarate
    Rodrigo Machado-Vieira
    [J]. Neuropsychopharmacology, 2017, 42 : 787 - 800
  • [48] Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders
    de Sousa, Rafael T.
    Loch, Alexandre A.
    Carvalho, Andre F.
    Brunoni, Andre R.
    Haddad, Marie Reine
    Henter, Ioline D.
    Zarate, Carlos A., Jr.
    Machado-Vieira, Rodrigo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 (04) : 787 - 800
  • [49] Targeting glutamatergic transmission in the development of novel therapeutics for mood and anxiety disorders
    Sanacora, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S142 - S142
  • [50] RNA therapeutics for mood disorders: current evidence toward clinical trials
    Le Marois, Marguerite
    Tzavara, Eleni
    Ibrahim, El Cherif
    Blin, Olivier
    Belzeaux, Raoul
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (07) : 721 - 736
12345